MedPath

Dead Space Closure With Quilting Suture Versus Conventional Closure With Drainage

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Procedure: Conventional closure with drainage
Procedure: Quilting suture without drainage
Registration Number
NCT02263651
Lead Sponsor
University Hospital, Tours
Brief Summary

The objective of this study is to compare quilting suture of the "dead space" without drainage of the pectoral area to conventional closure with drainage to prevent post-operative seroma requiring intervention (aspiration or surgical intervention) within 21 days after mastectomy for breast cancer.

Detailed Description

Eligible patients are patients with operable breast cancer (invasive carcinoma and/or carcinoma in situ) for whom mastectomy is recommended or preferred by the patient either alone or in association with sentinel lymph node biopsy or standard level I/II axillary node dissection

Randomization will be stratified by center and by type of surgery (mastectomy alone/ mastectomy with sentinel node biopsy / mastectomy with axillary lymph node dissection).

Two follow-up visits will be performed: at 21 days and 9 months after surgery, these appointments are conventional, thus our trial will not modify usual follow-up.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
320
Inclusion Criteria
  • Women ≥ 18 years and ≤ 85 years
  • Women with operable breast cancer (invasive carcinoma and/or carcinoma in situ) for whom mastectomy is recommended or preferred by the patient either alone or in association with sentinel lymph node biopsy or standard level I/II axillary node dissection
  • Women that give her informed written consent
  • French social security affiliation
Exclusion Criteria
  • Any physical or psychiatric condition that could impair with patient's ability to cooperate with postoperative data collection.
  • Women with indication of bilateral mastectomy or immediate reconstruction.
  • Degenerative neuromuscular disease with thoracic muscular damage
  • Planned ambulatory surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Closure with conventional technique with drainageConventional closure with drainageThe skin flaps are not fixed subcutaneously but sutured at the edges, a closed suction drain is inserted under the flaps in the dead space created by the dissection at the pectoral area. The drain is stitched to the skin.
Quilting suture without drainageQuilting suture without drainageIn an attempt to obliterate the dead space, the skin flaps are sutured to the underlying pectoralis major with multiple parallel rows of 0/0 vicryl (or equivalent). Running sutures at periodic intervals (\<2cm) are placed from the skin flaps to the underlying muscle.
Primary Outcome Measures
NameTimeMethod
Wound seroma requiring aspiration or surgical interventionWithin 21 days following mastectomy

A seroma is defined as a postoperative fluid collection via palpation on clinical examination. The Common Terminology Criteria for Adverse Events (CTCAE) which is a descriptive terminology that can be used for adverse event reporting provide a grading scale for seromas (lymphoceles).

Only grade 2 and 3 seromas i.e. seromas requiring one or more aspirations or a surgical intervention will be considered as primary outcome.

Secondary Outcome Measures
NameTimeMethod
Wound seroma whatever their type (requiring or not intervention)Within 9 months following mastectomy
Other wound complicationsWithin 9 months following mastectomy
Surgical morbidityDuring surgical intervention
PainBefore surgery, day 1, 21 days and 9 months following mastectomy

Visual Analogue Scale

Wound seroma requiring aspiration or surgical interventionWithin 9 months following mastectomy
Homolateral shoulder movementBefore surgery, 21 days and 9 months following mastectomy

The range of arm movement scored from 1 to 4 according to estimated angles of arm abduction as 1 (less than 90°), 2 (90-134°), 3 (135-179°) and 4 (180°)

Cosmesis results21 days, 9 months following mastectomy

Cosmetic results will be documented by patient,surgeon and by an blinded adjudication committee with possible response = poor, acceptable, good and excellent

Health related quality of life : EQ-5D-5LBefore surgery, day 1, 21 days and 9 months following mastectomy

The descriptive system comprises 5 dimensions : mobility, self care, usual activities, pain/discomfort, anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems

Cost-effectiveness assessmentDuring the whole follow-up period i.e. 9 months following mastectomy

Incremental net monetary benefice

Trial Locations

Locations (6)

Conception Hospital

🇫🇷

Marseille, France

CHRU de Tours

🇫🇷

Tours, France

Alliance Clinic

🇫🇷

St Cyr sur Loire, France

Institut de Cancérologie de l'Ouest

🇫🇷

Nantes, France

CHU de Poitiers

🇫🇷

Poitiers, France

Institut POALI-CALMETTES

🇫🇷

Marseille, France

© Copyright 2025. All Rights Reserved by MedPath